Fundraising Fox
Curve Biosciences
Dallas, US · Founded 2021 · 8 known investors
Find your way into Curve Biosciences
Each arrow is one introduction. Sign up to fill in the first one.
Ask Michael Y. Mashaal to introduce you to Nathan Hunkapiller
You →Michael · together at Natera →Nathan
Sign up to find every way you can get introduced to Curve Biosciences
- Your email: who you already know at Curve Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Curve Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Curve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients. The company works in molecular diagnostics and biotechnology, focused on more accurate patient monitoring.
Founders & leadership
Curve Biosciences was founded in 2021 by Nathan Hunkapiller and Prof. Shan Wang, PhD.
Board
Investors · 8
How we know: First Spark Ventures, Llc's portfolio page · funding news · biospace.com · the VCSheet dataset · Not right? Tell us
How we know: LifeX Ventures's portfolio page · funding news · biospace.com · Not right? Tell us
How we know: Luma Group's portfolio page · a partner's Signal profile · funding news · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: biospace.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$57.7M disclosed across 2 rounds · 2024–2025
- $40MraisedOct 2025 · 3 sources
Luma Group (lead), Civilization Ventures, First Spark Ventures, Incite, LifeX Ventures, Mintaka VC, NZVC, Techas Capital
Source ↗
▶$17.7MraisedMay 2024 · 64 investors · OtherRule 506(b)
- CHUBA OYOLUExecutive Officer
- NATHAN HUNKAPILLERExecutive Officer
- SHAN XIANG WANGExecutive Officer, Director
- THEMASAP KHANDirector
- RITISH PATNAIKExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $17.7M
- Minimum investment
- $1
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Curve Biosciences do?
- Curve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients. The company works in molecular diagnostics and biotechnology, focused on more accurate patient monitoring.
- Who founded Curve Biosciences?
- Curve Biosciences was founded by Nathan Hunkapiller, Prof. Shan Wang, PhD in 2021.
- Who are Curve Biosciences's investors?
- Curve Biosciences's investors include First Spark Ventures, Llc, LifeX Ventures, Luma Group, NZVC, Civilization Ventures Management, Llc, Mintaka.
- How much funding has Curve Biosciences raised?
- Curve Biosciences has disclosed $57.7M raised across 2 rounds.
- Where is Curve Biosciences headquartered?
- Curve Biosciences is headquartered in Dallas, US.